Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

BACKGROUND: Edaravone Dexborneol is a novel neuroprotective agent that comprised edaravone and (+)-borneol, a food additive with an anti-inflammatory effect in animal ischaemic stroke models. This study aims to assess the safety and efficacy of Edaravone Dexborneol compared with edaravone in treatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jie, Wang, Yilong, Wang, Anxin, Gao, Zhiqiang, Gao, Xiaoping, Chen, Huisheng, Zhou, Junshan, Zhao, Xingquan, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812637/
https://www.ncbi.nlm.nih.gov/pubmed/31709115
http://dx.doi.org/10.1136/svn-2018-000221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812637/
https://www.ncbi.nlm.nih.gov/pubmed/31709115
http://dx.doi.org/10.1136/svn-2018-000221

Ejemplares similares